TRACO - Center for Cancer Research:该给癌症研究中心.pptVIP

  • 3
  • 0
  • 约1.23万字
  • 约 70页
  • 2018-06-24 发布于浙江
  • 举报

TRACO - Center for Cancer Research:该给癌症研究中心.ppt

TRACO - Center for Cancer Research:该给癌症研究中心

* * The BB2R regulates EGFR tyrosine phosphoryation leading to increased cancer cell proliferation, survival and metastasis SUMMARY SCLC is a neuroendocrine tumor which initially responds to chemotherapy but subsequently relapse occurs. Multiple clinical trials are in progress to improve the treatment of SCLC patients. Smoking cessation. First line treatments approved by FDA. Nicotine replacement therapy (NRT) includes gum (Nicorette), patch (Nicoderm CQ) or nasal spray (Nicotrol) Pills. Bupropion is an antidepressant or Varenicline tartrate (Chantix) reduces smoking urge and withdrawal sympt

文档评论(0)

1亿VIP精品文档

相关文档